NASDAQ: IOVA · Biotechnology
Over the past week, Iovance Biotherapeutics (IOVA) saw about 128 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 35% bullish but is sharply divided: News runs 57% bullish while Reddit sits at just 22%. Wall Street is more constructive, with 8 of 10 analysts rating IOVA a buy.
There is little buzz around IOVA this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 80% buy share sits next to a crowd that ranges from Reddit at 22% to News at 57%. No other tracker puts the two side by side.
10 analysts have weighed in: a Strong Buy consensus: 8 buy calls against 0 sell, with an average 12-month price target of $13.30.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 45 points above the crowd average of 35%, the professionals are more constructive than retail. The split is inside the crowd: News reads 57% bullish while Reddit sits at 22%, a 35-point spread that single-source trackers miss.
Over the 30-day window, Iovance Biotherapeutics (IOVA) buzz held moderate around 48.4 while the price drifted up 70.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 19.3M shares. Updated Oct 10, 2026. Over the last 7 trading days, IOVA gained 2.7%. Buzz activity in the recent week averaged 43.3 and was variable, swinging between 33.9 and 57.5. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 20 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for IOVA and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IOVA sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (8 / 2 / 0) |
| Crowd bullish (7d) | 35% |
| Avg price target | $13.30 |
| Most bullish source | News, 57% |
| Most bearish source | Reddit, 22% |
| Sentiment spread | 35 pts |
| Mentions (7d) | 128 |
| Market cap | $6.03B |
| EPS · Beta | -$0.69 · 0.8 |
| Revenue (TTM) | $325M · -89% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Iovance Biotherapeutics (IOVA) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 35% bullish across 3 active sources. Those sources contribute 128 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Iovance Biotherapeutics (IOVA) is fairly quiet with 49 mentions over the last 7 days; the 30-day context spans 17 tracked subreddits. The 7-day tone is 22% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Iovance Biotherapeutics (IOVA), averaging 35% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 57% bullish and Reddit at 22%, a 35-point spread. On the professional side, 8 of 10 analysts rate IOVA a buy.
Of the 10 analysts covering Iovance Biotherapeutics (IOVA), 8 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $13.30. That puts the street ahead of the crowd, which averages 35% bullish.
Iovance Biotherapeutics (IOVA)'s cross-source average is bearish at 35% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. X reads 25% bullish, News reads 57% bullish and reddit coverage is the most negative at 22% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Iovance Biotherapeutics (IOVA) at 35% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is reddit at 22% bullish. 3-day activity momentum is falling across Reddit and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 72 mentions (56% of total volume). Reddit contributes 49 mentions and News contributes 7 mentions. The cross-source average is bearish at 35% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IOVA's sell signal at 93/100 conviction reflects a bearish cross-source average at 35% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The IOVA sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key